# Combination Treatment for Advanced Liver Cancer

> **NCT02149771** · PHASE3 · WITHDRAWN · sponsor: **Shanghai Zhongshan Hospital**

## Conditions studied

- Hepatocellular Carcinoma
- Hepatic Portal Vein Tumor Invasion

## Interventions

- **PROCEDURE:** chemoembolization
- **DEVICE:** endovascular stents implantation
- **PROCEDURE:** iodine-125 seed strand implantation

## Key facts

- **NCT ID:** NCT02149771
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Insufficient funding
- **Last updated:** 2018-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02149771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02149771, "Combination Treatment for Advanced Liver Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02149771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*